Brooks, Moore & Associates, Inc. Pfizer Inc Transaction History

Brooks, Moore & Associates, Inc.

$155 Million
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$32.09 - $37.51 $19,254 - $22,506	-600 Reduced 3.16%	18,366 $609,000
Q2 2023 Aug 15, 2023	SELL	$36.12 - $41.79 $10,836 - $12,537	-300 Reduced 1.56%	18,966 $696,000
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $141,804 - $184,608	3,600 Added 22.98%	19,266 $786,000
Q4 2022 Feb 03, 2023	BUY	$41.75 - $54.5 $35,988 - $46,979	862 Added 5.82%	15,666 $803,000
Q3 2022 Nov 17, 2022	SELL	$43.76 - $53.42 $3,282 - $4,006	-75 Reduced 0.5%	14,804 $648,000
Q1 2022 May 03, 2022	SELL	$45.75 - $56.69 $63,958 - $79,252	-1,398 Reduced 8.59%	14,879 $770,000
Q4 2021 Feb 04, 2022	SELL	$41.32 - $61.25 $8,305 - $12,311	-201 Reduced 1.22%	16,277 $961,000
Q3 2021 Nov 08, 2021	SELL	$39.25 - $50.42 $7,339 - $9,428	-187 Reduced 1.12%	16,478 $709,000
Q2 2021 Jul 21, 2021	BUY	$35.91 - $40.68 $18,421 - $20,868	513 Added 3.18%	16,665 $653,000
Q1 2021 May 04, 2021	BUY	$33.49 - $37.77 $77,495 - $87,399	2,314 Added 16.72%	16,152 $585,000
Q4 2020 Feb 08, 2021	SELL	$33.47 - $42.56 $6,694 - $8,512	-200 Reduced 1.42%	13,838 $509,000
Q3 2020 Nov 02, 2020	BUY	$31.75 - $37.25 $41,148 - $48,276	1,296 Added 10.17%	14,038 $515,000
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $338,368 - $410,490	-11,234 Reduced 46.86%	12,742 $417,000
Q1 2020 Apr 22, 2020	SELL	$27.03 - $38.62 $4,054 - $5,793	-150 Reduced 0.62%	23,976 $783,000
Q4 2019 Jan 30, 2020	SELL	$32.92 - $37.36 $73,543 - $83,462	-2,234 Reduced 8.47%	24,126 $945,000
Q3 2019 Oct 25, 2019	SELL	$32.49 - $42.13 $15,497 - $20,096	-477 Reduced 1.78%	26,360 $947,000
Q2 2019 Aug 09, 2019	BUY	$36.98 - $41.52 $53,547 - $60,120	1,448 Added 5.7%	26,837 $1.16 Million
Q1 2019 Apr 24, 2019	BUY	$37.5 - $41.2 $18,862 - $20,723	503 Added 2.02%	25,389 $1.08 Million
Q4 2018 Feb 06, 2019	BUY	$38.47 - $43.86 $957,364 - $1.09 Million	24,886 New	24,886 $1.09 Million

Others Institutions Holding PFE

# of Institutions

3,267

Shares Held

3.73B

Call Options Held

74.2M

Put Options Held

108M

Vanguard Group Inc Valley Forge, PA

516M
Shares

$13.8 Billion
0.27% of portfolio
Black Rock Inc. New York, NY

424M
Shares

$11.3 Billion
0.27% of portfolio
State Street Corp Boston, MA

287M
Shares

$7.67 Billion
0.36% of portfolio
Wellington Management Group LLP Boston, MA

166M
Shares

$4.44 Billion
0.85% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

130M
Shares

$3.48 Billion
0.73% of portfolio

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brooks, Moore & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brooks, Moore & Associates, Inc. with notifications on news.

Account